+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Rabies Vaccines Market by Vaccine Type, Vaccine Class, Route of Administration, Formulation, End User, Distribution Channel - Global Forecast to 2030- Product Image
Human Rabies Vaccines Market by Vaccine Type, Vaccine Class, Route of Administration, Formulation, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Human Rabies Vaccines Market by Vaccine Type, Vaccine Class, Route of Administration, Formulation, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674553
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Human Rabies Vaccines Market continues to evolve as growing public health demand, regulatory changes, and supply chain complexities drive innovation and strategic realignment among leading manufacturers and healthcare stakeholders. Industry executives navigating this dynamic sector must stay ahead of technology shifts, policy trends, and regional variations impacting procurement and pipeline decisions across the globe.

Market Snapshot: Human Rabies Vaccines Market

The Human Rabies Vaccines Market grew from USD 1.05 billion in 2024 to USD 1.10 billion in 2025. It is expected to sustain steady growth at a CAGR of 4.64%, reaching USD 1.38 billion by 2030. Rabies remains a significant public health priority due to its high fatality rate upon symptom onset and is managed primarily through effective vaccination programs. Global efforts to eliminate human rabies deaths focus on mass vaccination campaigns, improved surveillance, and increased access to prophylaxis. Active industry players are adapting product offerings and supply strategies to meet evolving clinical needs and regulatory expectations across regions.

Scope & Segmentation

This research delivers a comprehensive analysis of the market across critical dimensions, giving senior decision-makers precise insights into demand drivers, differentiation opportunities, and regional complexity.

  • Vaccine Types: Post Exposure Prophylaxis; Pre Exposure Prophylaxis
  • Vaccine Classes: Human Diploid Cell; Purified Chick Embryo Cell; Purified Vero Cell
  • Routes of Administration: Intradermal; Intramuscular
  • Formulations: Liquid; Lyophilized
  • End User Categories: Clinics; Hospitals; Research Institutes
  • Distribution Channels: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
  • Regions: Americas (including key US states, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (featuring UK, Germany, France, Russia, and others); Asia-Pacific (notably China, India, Japan, Australia, South Korea, and others)
  • Companies Profiled: Sanofi SA, GlaxoSmithKline plc, Bharat Biotech International Limited, Indian Immunologicals Limited, Valneva SE, China National Pharmaceutical Group, PT Bio Farma, Hualan Biological Engineering, Changchun Institute of Biological Products, Chengdu Institute of Biological Products

Key Takeaways

  • Intradermal regimens are strengthening vaccine access by lowering per-patient dosing requirements, offering a significant advantage for resource-constrained environments.
  • Recent advances in cell culture technology—such as the adoption of human diploid cell lines, purified chick embryo, and Vero cell systems—improve production consistency and response times during outbreak events.
  • Stakeholders are intensifying the focus on digital health platforms, supporting both adherence monitoring and supply analytics to further optimize patient outcomes and distribution efficiency.
  • Lyophilized, thermostable vaccine presentations allow for easier distribution in challenging climates, addressing gaps in immunization infrastructure and facilitating decentralized mass campaigns.
  • Strategic collaborations—including alliances between vaccine developers and contract manufacturers, as well as targeted M&A activity—are accelerating market penetration and delivering improved regional adaptability.
  • Emerging policy initiatives emphasize cross-sector alignment, integrating veterinary and human vaccination strategies to maximize public health impact.

Tariff Impact: Supply Chain Adaptation

Anticipated changes in United States trade policy for 2025 introduce additional tariffs on imported biopharmaceutical intermediates and raw materials, prompting manufacturers to reevaluate and diversify sourcing strategies. Key industry players are establishing new supplier partnerships within Asia-Pacific and EMEA regions to manage tariff exposure and ensure stable production capacity. This shift is concurrently driving renewed investment in domestic manufacturing facilities throughout North America and Europe, as organizations prioritize supply continuity and cost management. Adopting measures like long-term sourcing contracts and improved stockpiling practices will be crucial to mitigate the impact of these regulatory headwinds.

Methodology & Data Sources

This report is grounded in a robust, multi-phase methodology that combines primary and secondary research. In-depth interviews with immunologists, epidemiologists, and procurement leaders are complemented by analysis of regulatory filings, patent databases, trade data, and distribution analytics. Triangulation across data sources and rigorous peer review underpin data quality and objectivity.

Why This Report Matters

  • Identify the most relevant market opportunities by understanding the interplay of technology, policy, and healthcare demand across major regions and segments.
  • Benchmark against leading manufacturers to inform risk management, business expansion, and supply chain decisions.
  • Leverage segmentation and policy insights to optimize procurement strategies and accelerate time to market in diverse regulatory environments.

Conclusion

Senior decision-makers can leverage this analysis to craft agile, forward-looking strategies that align with technological innovation and evolving regulatory requirements. Effective collaboration and smart supply chain management will support rapid response in a changing human rabies vaccine landscape. Access the full report for tailored recommendations and deeper competitive intelligence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Rabies Vaccines Market, by Vaccine Type
8.1. Introduction
8.2. Post Exposure Prophylaxis
8.3. Pre Exposure Prophylaxis
9. Human Rabies Vaccines Market, by Vaccine Class
9.1. Introduction
9.2. Human Diploid Cell
9.3. Purified Chick Embryo Cell
9.4. Purified Vero Cell
10. Human Rabies Vaccines Market, by Route of Administration
10.1. Introduction
10.2. Intradermal
10.3. Intramuscular
11. Human Rabies Vaccines Market, by Formulation
11.1. Introduction
11.2. Liquid
11.3. Lyophilized
12. Human Rabies Vaccines Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Hospitals
12.4. Research Institutes
13. Human Rabies Vaccines Market, by Distribution Channel
13.1. Introduction
13.2. Hospital Pharmacies
13.3. Online Pharmacies
13.4. Retail Pharmacies
14. Americas Human Rabies Vaccines Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Human Rabies Vaccines Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Human Rabies Vaccines Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Sanofi SA
17.3.2. GlaxoSmithKline plc
17.3.3. Bharat Biotech International Limited
17.3.4. Indian Immunologicals Limited
17.3.5. Valneva SE
17.3.6. China National Pharmaceutical Group Co., Ltd.
17.3.7. PT Bio Farma (Persero) Tbk
17.3.8. Hualan Biological Engineering Inc.
17.3.9. Changchun Institute of Biological Products Co., Ltd.
17.3.10. Chengdu Institute of Biological Products Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. HUMAN RABIES VACCINES MARKET MULTI-CURRENCY
FIGURE 2. HUMAN RABIES VACCINES MARKET MULTI-LANGUAGE
FIGURE 3. HUMAN RABIES VACCINES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. HUMAN RABIES VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. HUMAN RABIES VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HUMAN RABIES VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY POST EXPOSURE PROPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PRE EXPOSURE PROPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HUMAN DIPLOID CELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PURIFIED CHICK EMBRYO CELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PURIFIED VERO CELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY INTRADERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 43. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 45. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 49. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 50. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 74. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 79. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 80. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 81. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 82. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 85. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 86. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 88. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 91. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 92. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 97. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 98. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 100. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 103. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 104. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 106. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 109. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 110. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 115. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 116. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 127. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 128. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 130. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 139. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 140. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 142. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 145. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 146. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 148. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 151. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 152. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 157. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 158. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 163. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 164. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 166. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. TURKEY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 169. TURKEY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 170. TURKEY HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 171. TURKEY HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 172. TURKEY HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. TURKEY HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. ISRAEL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 175. ISRAEL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 176. ISRAEL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. ISRAEL HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. NORWAY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 181. NORWAY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 182. NORWAY HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 183. NORWAY HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 184. NORWAY HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. NORWAY HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. POLAND HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 187. POLAND HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 188. POLAND HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. POLAND HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 190. POLAND HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. POLAND HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. SWITZERLAND HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 193. SWITZERLAND HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 194. SWITZERLAND HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 205. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 206. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 207. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 209. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. INDIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 212. INDIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 213. INDIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. INDIA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 215. INDIA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. INDIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. JAPAN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 218. JAPAN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 219. JAPAN HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. JAPAN HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 221. JAPAN HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. JAPAN HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. SOUTH KOREA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. THAILAND HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 242. THAILAND HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 243. THAILAND HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 244. THAILAND HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 245. THAILAND HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. THAILAND HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. PHILIPPINES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 248. PHILIPPINES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. SINGAPORE HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 260. SINGAPORE HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. VIETNAM HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 266. VIETNAM HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 267. VIETNAM HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. HUMAN RABIES VACCINES MARKET SHARE, BY KEY PLAYER, 2024
TABLE 278. HUMAN RABIES VACCINES MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human Rabies Vaccines market report include:
  • Sanofi SA
  • GlaxoSmithKline plc
  • Bharat Biotech International Limited
  • Indian Immunologicals Limited
  • Valneva SE
  • China National Pharmaceutical Group Co., Ltd.
  • PT Bio Farma (Persero) Tbk
  • Hualan Biological Engineering Inc.
  • Changchun Institute of Biological Products Co., Ltd.
  • Chengdu Institute of Biological Products Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.38 Billion
Compound Annual Growth Rate4.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Rabies Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Rabies Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Dog Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Dog Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Japan Rabies Vaccine Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Image

Japan Rabies Vaccine Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 82 Pages
  • Japan
From

About the Rabies Vaccine Market

The Rabies Vaccine market is a subset of the Vaccines market, which is a global industry that produces and distributes immunizations to protect against infectious diseases. Rabies Vaccines are used to protect against the rabies virus, which is a fatal disease that is spread through the saliva of infected animals. The Rabies Vaccine market is composed of a variety of products, including pre-exposure and post-exposure vaccines, as well as combination vaccines. These products are used in both humans and animals, and are typically administered by injection. The Rabies Vaccine market is highly regulated, with stringent safety and efficacy standards in place to ensure the quality of the products. Additionally, the market is subject to a variety of government regulations, including those related to pricing and distribution. Some companies in the Rabies Vaccine market include Merck & Co., Inc., Sanofi Pasteur, GlaxoSmithKline, and Pfizer, Inc. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.